Beyond the intratumoral immune landscape: lymph node heterogeneity and systemic immune networks shape responses to cancer immunotherapy
Year: 2026
Type: article
Abstract: Immune checkpoint blockade (ICB) has transformed cancer therapy, yet clinical benefit remains highly heterogeneous. Although the intratumoral immune landscape is central to understanding ICB efficacy, peripheral T-cell clonal dynamics highlight the importance of immune processes beyond the tumor microenvironment. Lymph nodes (LNs), particularly tumor-draining lymph nodes (TDLNs), contribute to systemic antitumor immunity through antigen presentation, T-cell priming, and the maintenance of tumor-reactive precursor populations. However, LNs are not functionally equivalent. In this Review, we examine the multiscale determinants of LN heterogeneity, including intranodal organization, tissue-specific immune imprinting, and regional lymphatic connectivity, and discuss tumor-induced remodeling and treatment-associated changes in LN function. We then consider the implications of LN heterogeneity for systemic antitumor immunity, immunotherapy responses, and potential clinical applications, including biomarker development and LN-directed therapeutic strategies. Finally, we propose testable hypotheses to guide future mechanistic and clinical investigations.
Source: Frontiers in Immunology
Institution: Academy of Military Medical Sciences
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235689301
